Envoy Medical (COCH) Payables (2021 - 2026)

Envoy Medical (COCH) has 6 years of Payables data on file, last reported at $6.8 million in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 310.83% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $6.8 million (up 310.83% YoY), and the FY2025 full-year result was $6.7 million, up 185.87% from the prior year.
• Payables advanced to $6.8 million in Q1 2026, from $6.7 million in the prior quarter.
• In the past five years, Payables ranged from a high of $6.8 million in Q1 2026 to a low of $658899.0 in Q1 2022.
• A 5-year average of $2.5 million and a median of $1.7 million in 2025 frame the typical range for Payables.
• Across the five-year window, Payables soared 1455.41% in 2022 and plunged 51.32% in 2024, its largest moves.
• Tracing COCH's Payables over 5 years: stood at $1.3 million in 2022, then soared by 39.39% to $1.9 million in 2023, then climbed by 25.63% to $2.3 million in 2024, then surged by 185.87% to $6.7 million in 2025, then gained by 1.94% to $6.8 million in 2026.
• Business Quant data shows COCH's Payables at $6.8 million in Q1 2026, $6.7 million in Q4 2025, and $5.3 million in Q3 2025.